Laparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer

Conditions: Early Gastric Cancer

Sex: All

Healthy volunteers: No

Phase: NA

Enrollment: 36

Sponsor: Jilin University

Location: the First Hospital of Jilin University Ch’ang-ch’un Jilin

Summary

This study is to evaluate the safety and efficacy of dual-endoscope assisted sentinel lymph node navigation surgery for early gastric cancer (EGC).

Eligibility Criteria

Inclusion Criteria: * Preoperative assessment indicating that the tumor was confined to the mucosa or submucosa, consistent with the diagnosis of early gastric cancer. * Patients who required additional surgical intervention following initial endoscopic submucosal dissection (ESD) based on postoperative pathological evaluation. * Patients and their families fully understood the procedure, requested dual-endoscope assisted sentinel lymph node navigation surgery, agreed to participate in this clinical study, and signed the informed consent form. Exclusion Criteria: * Preoperative assessment indicating suspected lymph node or distant metastasis. * History of complex abdominal surgery rendering laparoscopic treatment infeasible. * Participation in another clinical trial within 4 weeks prior to enrollment or currently participating in another trial. * History of severe psychiatric disorders. * Pregnant or lactating women. * Uncontrolled infection prior to surgery. * Presence of other malignancies or comorbidities that may significantly affect survival. * Any other conditions deemed by the investigators as unsuitable for participation, or refusal by the patient or family to enroll. * Cardiopulmonary, hepatic, and renal functions were unsufficient to tolerate the surgery.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07615374). StuddyBuddy aggregates publicly available trial information.